Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Tricida Inc.
Headquarters: South San Francisco, CA, United States of America
Website: N/A
Year Founded: 2013
Status: Out of Business
BioCentury | Aug 22, 2024
Management Tracks
Dimitrios Arkilo named CMO of Actio
Plus: Coya promotes Arun Swaminathan to CEO, and updates from Tempest and Incyclix
BioCentury | Oct 17, 2023
Management Tracks
Allogene named Geoffrey Parker as CFO
Plus: Summit hires Manmeet Soni as COO, and updates from SwanBio, DBV, Lyra and EyePoint
BioCentury | Apr 5, 2023
Data Byte
The market cap performance of the 2018 class of U.S. IPOs
At year-end, twice as many of the companies had lost value since their IPOs than gained value
BioCentury | Mar 24, 2023
Finance
Who’s gone? A snapshot of biotechs closing doors
Biotech struck by a wave of downsizing, restructuring and closures, as companies run out of options in an unforgiving market
BioCentury | Jan 13, 2023
Finance
4Q22 Wrap: Stopping the bleeding
Winners, losers across biotech market cap tiers in 4Q22
BioCentury | Jan 12, 2023
Deals
Jan. 12 Quick Takes: Cambrian launches Isterian to advance fibrosis programs
Plus: Oramed’s oral insulin misses in diabetes and Tricida going bankrupt
BioCentury | Oct 25, 2022
Product Development
Oct. 24 Quick Takes: Sumitovant’s $27 per share sweet enough for Myovant
Plus Alpine pivots and updates from Resolve, Imjudo, Syncona and more
BioCentury | Jul 14, 2022
Management Tracks
Cantrell joins Brii as CBO
Plus Chan Lee to be general counsel at BeiGene and updates from CytoDyn, Kezar, Anaveon, Fulcrum and more
BioCentury | May 20, 2022
Deals
May 19 Quick Takes: Be Biopharma, National Resilience partner
Plus Cambrian seeds women’s health subsidiary and updates from Pfizer, Tricida and more
BioCentury | Mar 4, 2022
Market Access
March 3 Quick Takes: ‘affordable’ insulin, finally, coming to U.S.
Plus Biogen starts layoffs and updates from Roche, ArrePath, NuCana, Tricida and more
Items per page:
1 - 10 of 39